学術論文 2019年の症例報告・英文を更新しました。
【原著，英文】
1.Minami T, Ishida W, Hino S, Matsunaga T, Fukushima
A, Yamagami S. In vitro and in vivo performance of epinastine
hydrochloride releasing contact lenses. PLOS ONE, Published: January 30, 2019. https://doi.org/10.1371/journal.pone.0210362
2.Saito H, Kagami S, Mishima K, Mataki N,
Fukushima A,Araie M. Long term side effects including blepharitis
leading to termination of 0.4% ripasudil, a rho-kinase inhibitor, in
glaucoma patients of a clinical setting. J Glaucoma, in press.
3. Sakamoto E, Ishida W , Sumi T, Kishimoto T, Tada
K, Fukuda K, Yoneda T, Kuroiwa H, Terao E, Fujisawa Y, Nakakura S, Jian
K, Okumichi H, Kiuchi Y, FukushimaA. Evaluation
of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor;
0.4% Ripasudil ophthalmic solution clinical trial. Sci Rep, in press.
【症例報告,英文】
1.Fukuda K, Ishida W, Kishimoto T, Fukushima A. Development of
conjunctivitis with a conjunctival proliferative lesion in a patient
treated with dupilumab for atopic dermatitis. Allergol Int, in press.
2.Kishimoto T, Fukuda K, Nishiuchi T, Hayashi N, Fukushima A. Unilateral
serous retinal detachment with choroidal thickening as a first
presenting sign of acute myeloid leukemia. American Journal of
Ophthalmology Case Reports 14:51-54,2019.
3.Miura Y, Fukuda K, Taniguchi Y, Komori M, Fukushima A. Recurrent optic
perineuritis as the first manifestation of relapsing polychondritis.
Journal of Neuro-Ophthalmology, in press.
